This presentation focuses on approaches to psychopharmacology for people at clinical high risk for psychosis or who are early in the course of a psychotic illness. We will discuss when it is appropriate to start antipsychotic medication and how to work with patients/families around the starting of medication. We will have a discussion of evidence-based medications for psychosis, including clozapine, and other adjunctive medications to consider in addition to antipsychotics. We will also have a discussion of the newest antipsychotics on the market and how to consider their use in this population.
This activity was developed in partnership with the Psychosis-Risk and Early Psychosis Program Network (PEPPNET).
Format
Recorded webinar, non-interactive, self-paced distance learning activity with post-test.
This presentation was recorded on September 24, 2020.
Learning Objectives
- Identify key differences in use of medications in first-episode psychosis (FEP) vs. clinical high risk (CHR).
- Describe three tools for working with families and consumers on understanding the role of medication in treatment.
- Summarize current evidence-based medications for psychosis and new medications available in the market.
Target Audience
Psychiatrist, Pharmacist, Physician (non-psychiatrist), Physician Assistant, Nurse/Nurse Practitioner
Instructional Level
Introductory, Intermediate
Estimate Time to Complete
Estimated Duration: 1.0 hour
Program Start Date: September 24, 2020
Program End Date: September 24, 2026
Ongoing Interdisciplinary Discussion Board
After completing the course, engage with colleagues in the mental health field through SMI Adviser's Webinar Roundtable Topics discussion board. This is an easy way to network and share ideas with other clinicians who participate in this webinar. Access through the discussion tab.
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course, including viewing the full video and submitting an evaluation. A multiple-choice quiz is provided based on the content. A passing score of 75% must be achieved. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (other disciplines) showing the completion date and hours/credits earned.
Continuing Education Credit
Physicians
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
Instructor
- Jacob Ballon, MD, MPH, specializes in the treatment of people with psychotic disorders, including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford, which provides interdisciplinary care for people experiencing psychosis. He is also the medical director of H2 acute inpatient unit and the co-director of the specialty psychiatry clinics section in the Department of Psychiatry. Disclosure - Consultant: Alto Pharmacy, Corcept.
Planners
- Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests.
- Amy N. Cohen, PhD, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Judith Dauberman, PhD, Stanford University. Reports no financial relationships with commercial interests.
- Tristan Gorrindo, MD, American Psychiatric Association. Reports no financial relationships with commercial interests.
Reviewers
- Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests. (Reviewed on 9/5/2023)
- Amy N. Cohen, PhD, American Psychiatric Association. Reports no financial relationships with commercial interests. (Reviewed on 8/24/2023)
- John Torous, MD, Beth Israel Deaconess Medical Center. Dr. Torous has no relevant financial relationships to disclose. (Reviewed on 8/18/2023)
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This website requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact SMIadviserhelp@psych.org for technical assistance